Moderate

A patient taking an aromatase inhibitor for breast cancer asks why bone health is monitored. Which explanation is correct?

Correct answer: A. Reduced oestrogen can accelerate bone loss and increase fracture risk

  • A. Reduced oestrogen can accelerate bone loss and increase fracture risk
  • B. Increased oestrogen causes excessive calcium deposition in the arteries
  • C. The medicine directly blocks calcium absorption in the intestine
  • D. The medicine commonly causes parathyroid hormone deficiency

Explanation

Aromatase inhibitors reduce oestrogen production, and low oestrogen promotes bone resorption. Long-term treatment can therefore reduce bone mineral density, so fracture risk and bone health require monitoring.

Submitted by a TestUstad contributor and published by the TestUstad editorial teamLast updated
Report an error

The more specific you are, the faster it gets fixed. A source beats an opinion.

Prefer email? support@testustad.com

About Endocrine and Diabetes Drugs

Endocrine pharmacology includes insulin preparations, oral antidiabetic drugs, thyroid and antithyroid medicines, corticosteroids, sex hormones and drugs affecting calcium balance. Questions address onset and duration, administration, monitoring, hypoglycaemia, steroid adverse effects and the difference between replacing a deficient hormone and suppressing excessive hormone activity.

Practise Endocrine and Diabetes Drugs

50 free Endocrine and Diabetes Drugs MCQs from Nursing Pharmacology, each with the correct answer and an explanation. Unlimited attempts, no account needed.

Discussion

Stuck on an option, or know a faster way to get there? Ask or explain it here.

No comments yet. Be the first to explain this one.

Exams that ask Nursing Pharmacology questions like this

Nursing Pharmacology is on 8 papers prepared for on TestUstad, and all of them draw the same bank, so this question is worth knowing for every one of them.

More Endocrine and Diabetes Drugs questions